1. BarnettJD, Mellonig JT, GrayJL, Towle HJ. Comparison of freeze-dried bone allograft and porous hydroxylapa-tite in human periodontal defect. J Periodontal 1989: 60: 231-7.
2. Bernard GW. Healing and repair of osseous defects. Dent Clin North Am 1991: 35:469-77.
3. BowenJA, MelloningJT, GrayJL, Towle HT. Comparison of decalcified freezedried bone allograft and porous particulate hydroxylapatke in human periodontal osseous defect. J Periodontal 1987: 60:647-63.
4. Cafesse R, Sweeney EP, Smith R. Scaling and root planning with and without periodontal surgery.,/Clin Periodontal 1986: 13:205-9..
5. Carranza FA, Shklar G. The historical background of periodontology. Glickman's Clinical Periodontology, MB Saunders Company: 1990: 1-11.
6. Ciancio SG, Genco RJ, Shalhorn RG, Goodson JM. Non surgical antibacterial periodontal treatment. JADA 1988: 116: 22-32.
7. Drisko CL, Cobb CM, Killoy WJ, Michalowics BS, Pihlstrom BL, Lowenguth RA, Caton JG, Encarnacion M, Knowles M, Goodson MJ. Evaluation of periodontal treatment using controlled release tetracycline fibers: Clinical Response J Periodontal 1995: 66: 692-9.
8. Feldman RS, Szeto B, Chauncey HH, Goldhaber P. Nonsteroidal antiinflammatory drugs in the reduction of human alveolar bone loss. J CRn Periodontal 1983: 10:131-6.
9. Fine DH. Chemical agent to prevent and regulate plaque development. Periodontolo® 2000 1995:8: 87-107.
10. Genco IİJ. Antibiotics in the treatment of human periodontal disease. J Periodontal 198.1: 52.545-58.
11. Golhaber P. Tissue culture studies of bone as a model system for periodontal research. J Dent Res 1971: 50: 278-87.
12. Golub LM, McNamara TF, D'Angels G, Greenvald RA, Ramamurhy N. A non-antimicrobial chemically modified tetraccline inhibits mammalian collegenase activity. J Dent Res 1987: 66: 1310-4.
13. Golub LM, Ramamurthy N, McNamara TF ct al. Tetracyclines inhibit tissue collagenaze activity: A new mechanism in the treatment of periodontal disease. JPeriodontRes 1984: 19:651-5.
14. Goodson JM. Diagnosis of periodontitis by physical measurement: interpretation from episodic disease hypothesis. JPeriodontoll992: 63: 373^2.
15. Gordon JM, Clay BW. Current status of systemic antibiotic usage in destructive periodontal disease. JPeriodontol 1993: 64.-754-68.
16. GottlowJ, Nyman S, LindleJ, Karring T, Wcnnstrom J. New attachment formation in the human periodontium by guided tissue regeneration. J Clin Periodontol 1986: 13: 604-16.
17. Greenstein G. Periodontal response to mechanical non surgical therapy. A Review. JPeriodontol 1992: 63: 118¬30.
18. Haesman PA, Seymour RA. A association between long term non-steroidal antiinflammatory drug therapy and the severity of periodontal disease./ Clin Periodontol 1990: 17: 654-8.
19. Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal disease. Peridontology 20001994: 5; 78-111.
20. Haffajee AD, Socransky SS, LindheJ, Kent RL, Oki-mato H, Yoneyama T. Clinical risk indicators for periodontal attachment loss. J Clin Periodontol 1991: 18:117-25.
21. Howell HT. Blocking periodontal disease progress^ on with anti-inflammatory agents. J Periodontol 1993: 64: 819-827.
22. Lang NP. Indications and rational for non surgical periodontal therapyj/nf Dentl983: 127-32.
23. LindheJ, Nyman S. Scaling and granulation tissue removal in periodontal therapy. J Clin Periodontal 1985: 12: 374-8.
24. LindheJ, Westfelt E, Nyman S, Socransky S, Haffajee AD. Long-term effect of surgicai-non surgical treatment of periodontal disease./CKn Periodontol 1984: //: 448-58.
Periodontal
Tedavi Yöntemlerine Genel Bir Yaklaşım
57
25. Listgarten MA. The structure of dental plaque. Periodontology 2000 1994:5: 52-65.
26. Loesche WJ. Chemotherapy of dental plaque infections. Preventive Dentistry. Nature, pathogenicity and clinical control of plaque eds. Melcher AH, Zarb GA Oral Sciences Reviews: 1976: 65-107.
27. Low SB, Ciancio SG. Reviewing non surgical periodontal therapy./AmZ>en;/W1990: 121: 467-70.
28. Lynch SE, Ruiz de Castilla G, Williams RC, et al. The effects of short application of a combination of platelet-derived and insulin like growth factors on periodontal wound healing. J Periodontal 1991: 62:458-64.
29. Lynch SE, William RC, Poison AM et al. A combination of platelet -derived and insulin like growth factors enhances periodontal regeneration. J Clin Periodontol 1989: 16:543-8.
30. MellonigJT, Bowers GM, Bright RW, Lawrence JJ. Clinical evaluation of freeze dried bone allografts in periodontal osseous defects. /Periodontoll976: 47:125-31.
31. Moore WEC, Moore LVH. The bacteria of periodontal diseases. Periodontology 20001994; 5:66-77.
32. Newman MG, Kornman KS, Daherty FM. A 6 month multicenter evaluation of adjunctive fiber therapy used in conjunction with scaling and root planning in maintenance patient: Clinical results./Periodontol 1994: 65: 685-91,
33. Nyman S, GottlowJ, Karring T, LindeJ. The regenerative potential of the periodontal ligament./ CUn Periodontol 1982: 9: 257-65.
34. Nyman S, GottlowJ, LindheJ, Karring T, Wenns-trömj. New attachment formation by guided tissue regeneration .JPeriodontRes 1987: 22: 252-4.
35,Offenbahenlkjn S, Farr DH, Goodson JM. Measurement of prostaglandin E in crevicular fluid./ Clin Periodontal 1981: 5:359-67.
36. Page RC. Periodontal Therapy: Prospects for the future. J Periodontol 1993: 64: 744-53.
37. Page RC. Periodontal Therapy: Prospects for the fu¬ture./Periodontol 1993: 64: 744-53.
38. Page RC. The role of inflammatory mediators in die pathogenesis of periodontal diseases. J Periodont Res 1991: 26: 230-42."
39. Philstrom BL, McHugh RB, Oliphant TH, Cortiz-Campos C. Comparison of surgical and non surgical treatment
of periodontal disease. A review of current studies and additional results after 6 and one half years. JQin Periodon-toi 1983: /Ö.-524-42.
40. Rifkin BR, Verlins AT, Golup LM. Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: A potential therapeutic role for tetracyclines and their chemically-modified analogs. / Periodontol 1993: 64: 819-27.
41. RummelhartJM, MellonigJT, GrayJL, Towic HJ. A comparison of freeze dried bone allograft and deminerali-zed freeze dried bone allograft in human periodontal osseous defects./Periodontol 1989: 60: 655-63.
42. Slots J, RamsT. Antibiotics in periodontal therapy, advantages and disadvantages./ din Periodontol 1990: 17: 479-93.
43. Socransky S, Haffajee AD. Microbiology (plaque). Grant DA, Stern B, Listgarten MA. Periodontics. 6th edition. St Louis: CV Mosby Co: 1988: 147-97.
44. Socransky SS, Haffajee AD. Effect of therapy on periodontal infections. J Periodontol1993: 64:754-9.
45. Stahl SS, Froum ST. Histological evaluation of human intraosseous healing responses to the placement of tri-calcium phosphate ceramic implants. Three to eight months./PeriodontonWG: 57: 211-7.
46. Waite IM, Saxton CA, Young A, Wogg BJ, Carbett M. The periodontal status of subjects receiving long term nonsteroidal antiinflammatory drug. J Dent Res 1981: 100-8.
47. Walker CB, PappasJD, Tyler KZ, Kohen S, Gordon JM. Antibiotic susceptibilities of periodontal bacteria. In vitro susceptibilities to 8 antimicrobial agents.J Periodontol 1985: 56(suppl): 67-74.
48. WiederSG, Newman HN, StrahanJD. Stannous flou-ride and subgingival chlorhcxidine irrigation in the control of plaque and chronic periodontitis./Qin Periodontol 1983: 10: 172-81.
49. Wikesjo UME, Baeker PJ, Christersson LA, Geneo RJ, Lyall RM, Hie S, Di Florio RM, Terranova VP. A biochemical approach to periodontal regeneration. Tetracycline trcatmant conditions surfaces. J Periodont Res 1986: 27:322¬9.
50. Willey R, Steinberg AD. Scanning electron microscope studies of root dentin surfaces treated with citric acid, elatasc, hyaluronidase, pronase and collagenase./Pmoc/on-io/1984: 55:592-6.
Thank you for copying data from http://www.arastirmax.com